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Abstract
Background: India is endemic for enteric fever, and it is not known whether the variations in clinical manifestations
between patients are due to host, environmental or pathogen factors.
Blood culture surveillance was conducted at St. John’s Medical College Hospital, Bangalore, between July 2016 and
June 2017. Clinical, laboratory and demographic data were collected from each case, and bacterial isolates were
subjected to whole genome sequencing. Comparative analysis between adults and paediatric patients was carried
out to ascertain differences between adult and paediatric disease.
Results: Among the 113 cases of blood culture-confirmed enteric fever, young adults (16–30 years) and children <
15 years accounted for 47% and 37% of cases, respectively. Anaemia on presentation was seen in 46% of cases, and
19% had an abnormal leucocyte count on presentation. The majority received treatment as inpatients (70%), and
among these, adults had a significantly longer duration of admission when compared with children (p = 0.002).
There were atypical presentations including arthritis, acute haemolysis and a case of repeated typhoid infection
with two separate S. Typhi genotypes. There was no association between infecting genotype/serovar and treatment
status (outpatient vs inpatient), month of isolation, duration of admission, patient age (adult or child), antimicrobial
susceptibility, Widal positivity or haematologic parameters.
Conclusions: Amidst the many public health concerns of South India, enteric fever continues to contribute
substantially to hospital burden with non-specific as well as uncommon clinical features in both paediatric and
adult populations likely driven by host and environmental factors. Robust clinical surveillance as well monitoring of
pathogen population structure is required to inform treatment and preventive strategies.
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Background
The Indian subcontinent is endemic for enteric fever, a
febrile illness caused by Salmonella enterica serovars
Typhi (S. Typhi) and Paratyphi A (S. Paratyphi A), and
on a global scale causes an estimated 14 million cases of
febrile illness annually [1], disproportionally affecting
children and young adults [2–4].
The most common circulating genotype of S. Typhi in
South Asia is H58 (4.3.1) [5]. Longitudinal as well as a
cross-sectional data from two separate hospital-based stud-
ies in Southern India confirmed that 4.3.1 was the dominant
genotype in both settings, making up 77.8% and 88.2 % of
the pathogen population in the respective study sites [6, 7].
Here, we present clinical data from one of these stud-
ies (Bangalore, 2016–2017), including the age distribu-
tion and clinical phenotype of patients confirmed with
enteric fever. We highlight rare presentations, contrast-
ing features of adult and paediatric enteric fever, and in-
vestigate the association of these with the molecular
structure of the pathogen population.
Main text
Methods
This hospital-based surveillance took place in a tertiary
care setting in Bangalore, South India, as described pre-
viously [7]. For the purpose of this study, between June
2016 and June 2017, every microbiological specimen
(113 blood cultures and 1 joint aspirate) that was posi-
tive for a typhoidal Salmonella organism (confirmed by
biochemical and serological means) was stored. The
stored isolates were then sequenced, and the identity of
these genomes were confirmed by multilocus sequence
typing (MLST) and subsequently genotyped as described
previously [7]. These were then linked to electronic pa-
tient records for relevant demographic and laboratory
(complete blood counts, liver function tests and Widal
serology) details after relevant ethics approvals [7].
Results
Forty children (up to 15 years of age) and 73 adults had
a culture-confirmed diagnosis of enteric fever during the
study period. There were 114 unique isolates (100 S.
Typhi and 14 S. Paratyphi A) from these 113 patients
(one patient had two separate episodes of S. Typhi infec-
tion). The age distribution of patients (73 adults and 40
children) and infecting genotypes/serovars are illustrated
in Fig. 1. There was no seasonal trend in disease occur-
rence indicating perennial transmission (Figure S1).
Adults made up 65.5% of cases and 62.9% were male.
The majority of cases occurred in children (age ≤ 15
years, n = 40, 35.1%) and young adults (age 16–30 years,
n = 53, 46.5%; Fig. 1). The majority of patients were
treated on an inpatient basis (68.9%), and there was no
difference in serovar/genotype distribution among
inpatients and outpatients nor in likelihood of admission
to hospital between those infected with S. Typhi vs S.
Paratyphi A (OR = 2.96, p = 0.15) or between children
and adults (OR = 0.6, p = 0.25). The median duration of
admission for adults was 4.5 days (IQR, 3–6), signifi-
cantly longer than for children (2 days, IQR, 1–4; p =
0.002 using Wilcoxon’s rank sum test).
Data on haemoglobin (Hb), total white blood cell
(WBC) count and platelet count on presentation, strati-
fied by adults and children, are illustrated in Fig. 2. Chil-
dren (age ≤ 15 years) had significantly lower Hb values
on presentation in comparison with adults (p = 0.002,
Mann-Whitney U Test). A peripheral smear was done at
the same time point as Hb estimation in 31 children and
24 adults, and only 3 children and 5 adults had a micro-
cytic hypochromic (MCHC) blood picture. Leucopenia
on admission was observed in 2 (6.1%) children and 8
(13.6%) adults while leucocytosis was seen in 8 (24.3%)
and 9 (15.3%) children and adults, respectively. The
WBC count did not differ significantly between adults
and children on admission and, in the majority of cases,
remained within the normal range until resolution of
disease (Fig. 2). Two adults and two children had abnor-
mally high WBC counts suggestive of a leukaemoid reac-
tion. The two adults had repeated WBC counts during
the course of the disease, and their leucocyte counts
normalised with the initiation of cephalosporin treat-
ment. Thrombocytopenia was seen in 24.7% of patients,
and it was more common in adults but this difference
was not significant.
Fifty-five patients had liver function tests at presenta-
tion. Raised liver enzymes were significantly more com-
mon among adult cases (n = 30, 54.5%) than paediatric
cases (n = 5, 9%; p = 0.001 using Mann-Whitney U
Test). The Widal test was undertaken at a single time
point at presentation in all patients and was positive
(above a titre of 1:160 for the O and H antigens) in only
68% of patients. Among children, 26 out of 37 infected
with S. Typhi (70%) had a positive Widal test, vs 44 out
of 66 (66%) adults (p = 0.6). There was also no associ-
ation between Widal positivity and infecting genotype of
S. Typhi. All patients made a full recovery with 14 days
of third generation cephalosporin treatment which in-
cluded intravenous ceftriaxone for 5–7 days and oral
cefixime for the remaining days.
The genotypic population structure was dominated by
the S. Typhi 4.3.1 genotypes, particularly the 4.3.1.2
lineage, with a number of prominent fluoroquinolone re-
sistance molecular mechanisms as described previously
[7]. Here, we describe the wider contextualisation of
genetic relatedness of S. Typhi strains and the relation
to clinical outcomes. A whole genome phylogeny for S.
Typhi 4.3.1 (H58) was constructed comprising the 100
isolates from this study with 1133 from a global
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collection [5] (Figure S2). The strains isolated from
countries of the Indian subcontinent clustered closely
together, and the intermingling of isolates from adults
and children suggests that transmission occurred be-
tween these groups as opposed to separate independent
transmission cycles in adults and children. The strains
clustered together irrespective of clinical outcomes such
as anaemia, leucopoenia, leucocytosis, leukaemoid reac-
tion, thrombocytopenia, abnormal liver enzymes and
Widal positivity.
There were several noteworthy clinical scenarios ob-
served over the course of the study period. A 26-year-
old male patient presented with pain in the right hip.
Clinical examination revealed decreased mobility at the
hip joint along with painful movements, local rise in
temperature and tenderness. A clinical diagnosis of sep-
tic arthritis was made (radiologic images illustrated in
Figure S3) which was confirmed via bacteriologic culture
of joint fluid aspirate that grew S. Typhi (genotype
4.3.1.2). This patient had no history of a haematologic or
immunologic abnormality, and his peripheral smear at
the time of diagnosis was normocytic and
normochromic.
A 5-year-old child presented with fever and acute dys-
pnoea with clinical examination and preliminary labora-
tory findings suggestive of acute haemolysis. The child
was found to have a haemoglobin (Hb) level of 4 g/dl in
addition to a positive blood culture for S. Typhi (geno-
type 4.3.1.2). Further haematological workup of this pa-
tient revealed a diagnosis of hereditary spherocytosis
based on a positive osmotic fragility test with a haemo-
lytic episode precipitated by S. Typhi infection.
There were instances where S. Typhi was isolated from
the same patient on two separate occasions. In 3 of
these, the organism (S. Typhi genotype 4.3.1.2) was iso-
lated during the same admission, > 48 h apart, despite
initiation of injectable cephalosporin therapy, highlight-
ing an increased clearance time despite the organism be-
ing susceptible to the antimicrobial. In all 3 of these
cases, the isolates clustered tightly with other 4.3.1.2 iso-
lates in the phylogenetic tree indicating no unique viru-
lence features. In another instance, a confirmed
Fig. 1 Age-stratified distribution of typhoidal Salmonella genotypes. Indian S. Typhi genotypes stratified according to age group. Individual S.
Typhi genotypes and S. Paratyphi A lineages are coloured as described in the inset legend
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Fig. 2 Haematological parameters of cases identified through this study. Haematological values of patients infected with typhoidal Salmonella on
admission and trends over the course of disease according to inset legend. The dashed lines represent the cut-offs for the haematological parameters
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diagnosis was made 2months apart with two different S.
Typhi genotypes, namely H58 lineage 2 (4.3.1.2) followed
by a genotype 2.2.2 isolate 2 months later, possibly indi-
cating an environmental risk for this individual.
Discussion
These data provide insights into clinical spectrum of en-
teric fever in adults and children in an endemic region.
The high-resolution analysis of pathogen genomic data
along with clinical and laboratory data seems to suggest
the modest role of pathogen virulence in determining
clinical outcomes.
The large proportion of patients who were treated
as inpatients is a possible reflection of disease sever-
ity, although this is also likely to be due to bias
owing to the more rigorous testing in those patients
who had clinical manifestations requiring inpatient
care. It is interesting to note that adults had signifi-
cantly longer duration of hospital admission when
compared with children. This may indicate a more
rapid clearance of bacteraemia in children, or it may
be due to children presenting earlier with less severe
disease due to concerned parents and subsequently
having a lower threshold for admission. The perennial
pattern of disease occurrence could suggest that the
endemic nature of disease occurs through contamin-
ation of water supplies as opposed to point-source
outbreaks.
The significant difference in Hb on admission between
children and adults in this study was unexpected, and
since the majority of these had a normocytic normo-
chromic blood picture, it is likely that the anaemia was
due to acute typhoid infection as opposed to nutritional
deficiency. The relatively small proportion of patients
with abnormal WBC counts was also surprising when
compared with those of the human challenge model [8],
where leucopoenia was observed shortly before the onset
of clinical manifestations—in particular lymphopenia,
neutropenia and eosinophilia [8]. This model used the
same pathogen strain (genotype 3.1) to infect all partici-
pants, and the clinical as well laboratory features differed
widely [8]. The difference in WBC count findings be-
tween volunteers in human challenge studies and this
cohort of patients could be due a number of reasons in-
cluding the discrepancy in sampling times and disease
progression as well as repeated natural subclinical en-
teric fever infections leading to immune priming among
patients in this study [9]. This may also be the reason
for the non-reliability of the Widal test in endemic re-
gions, particularly when it is done at a single time point
as seen in this cohort of patients. Widal positivity rates
were higher in children which may indicate a higher de-
gree of immune naivety/lower rates of subclinical infec-
tions when compared with adults.
Salmonella bone and joint infections are more com-
mon with non-typhoidal Salmonella and most com-
monly seen in association with sickle cell disease [10].
The young adult in this study with septic arthritis was
haematologically normal and had no prior right hip
pathology. He made a full recovery with cephalosporin
treatment, and follow-up after 6 months showed no re-
sidual joint pathology.
In the other case of a 5-year-old with hereditary spher-
ocytosis, acute haemolysis in patients with structural red
cell defects due to infection with S. Typhi has never been
documented before, to our knowledge. Interestingly, the
diagnosis of hereditary spherocytosis was made only
after this infection. The patient received a blood transfu-
sion during admission along with cephalosporin therapy
and made a complete recovery. In both these cases, the
organism cultured belonged to the 4.3.1.2 genotype and
was fluoroquinolone non-susceptible with two QRDR
SNPs (gyrA and par) in the first case and three QRDR
SNPs in the second case. Both these isolates also clus-
tered tightly within the local S. Typhi 4.3.1.2 population
(Figure S2) suggesting they are typical of locally circulat-
ing strains.
Although mathematical models suggest about 5 child-
hood infections are required to induce life-long protec-
tion [11], this has not been demonstrated in the field or
in experimental laboratory settings and has important
implications when designing vaccination schedules in
terms of interval between doses and selection of vaccine
antigens. A 28-year-old male among the cohort of cases
in this study was treated on an outpatient basis in April
2017. The infecting agent was a 4.3.1.2 genotype strain.
Two months later in June 2017, he was again diagnosed
with enteric fever and the infecting genotype was 2.2.2.
On both occasions, the patient was treated with a ceph-
alosporin and made a complete recovery. It is not known
whether the difference in genotype is sufficient to escape
natural immunity and allow a second infectious episode,
or whether this would have occurred regardless of the
infecting genotype.
Our study has limitations as all isolates examined were
from a single hospital-based passive surveillance
programme and thus may not be representative of the
disease trends in the wider community. The laboratory
data analysis included only routine haematological and
laboratory tests at admission and discharge. We also did
not actively survey all febrile cases coming to the hos-
pital, and it is known that hospital-based active surveil-
lance of enteric fever yields a higher number of cases
[12]. However, the age distribution trends observed here
are similar to those seen in larger community-based
studies from the region [3] and support the idea that
vaccination strategies should be aimed at children and
young adults in endemic regions.
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Conclusions
These data constitute the first study of blood culture-
confirmed enteric fever in India linking clinical features
and high-resolution pathogen genomics. In Southern
India, enteric fever continues to be a public health issue
with non-specific and sometimes atypical presentations,
likely driven by the host-response and environmental
factors. Children and young adults account for a sub-
stantial proportion of the disease burden with certain
clinical features differing between children and adults.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s41182-020-00247-2.
Additional file 1: Figure S1. Temporal distribution of typhoidal
Salmonella serovars. Representation of typhoidal serovars, treatment
status and genotype distribution as per the inset legends between adults
and children over the study period. Figure S2. Phylogenetic tree of 4.3.1
(H58) S. Typhi isolates from Bengaluru and a global collection. This tree is
made up of all 100 4.3.1 isolates from this study plus 1133 globally
representative 4.3.1 isolates, and the rings are coloured according to the
inset legend. The intermingling of isolates of children and adults is
evident from the coloured branches and ring1. Branch lengths are
indicative of the estimated number of substitutions rate per variable site;
the tree was outgroup rooted using S. Paratyphi A strain AKU_12601.
Figure S3. Radiological imaging of the right hip joint of a patient with
septic arthritis due to S. Typhi (red arrows point to regions of interest as
mentioned in the description of each panel). Panel A: CT image,
transverse section, showing irregularity and erosions due to the infective
process with no obvious breach in cortex. Panel B: MRI image, transverse
section, showing involvement of the right iliac crest ,acetabular roof,
head of the femur (cystic change), greater and lesser trochanter. Panel C:
MRI image, T2W coronal view, shows the extent of bony involvement
with effusion in the joint space. Panel D: MRI image, T2W, shows
inflammation of the surrounding soft tissue including right iliacus muscle.
Left hip joint appears normal.
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